日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort study

免疫检查点抑制剂联合化疗用于IV期胃癌转化治疗:一项多中心回顾性队列研究

Huang, Xingmao; Chen, Xiangliu; Chen, Jiahui; Hu, Can; Chen, Han; Chen, Hang; Fang, Jingquan; Ye, Zeyao; Du, Yian; Yu, Pengfei; Huang, Ling

Genomic and immune microenvironment features influencing chemoimmunotherapy response in gastric cancer with peritoneal metastasis: a retrospective cohort study

基因组和免疫微环境特征影响胃癌腹膜转移患者的化疗免疫治疗反应:一项回顾性队列研究

Yu, Pengfei; Ding, Guangyu; Huang, Xingmao; Wang, Chenxuan; Fang, Jingquan; Huang, Ling; Ye, Zeyao; Xu, Qi; Wu, Xiaoying; Yan, Junrong; Ou, Qiuxiang; Du, Yian; Cheng, Xiangdong

Clinicopathological features and prognostic significance of TAF1L in gastric cancer.

TAF1L在胃癌中的临床病理特征及预后意义

Chen Han, Chen Hang, Fang Jingquan, Huang Xingmao, Zhu Xiu, Chai Tengjiao, Chen Xiangliu, Huang Ling, Yu Pengfei

SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score-matched analysis

SOX联合信迪利单抗与单用SOX治疗局部晚期胃癌围手术期疗效比较:一项倾向评分匹配分析

Huang, Xingmao; Fang, Jingquan; Huang, Ling; Chen, Hang; Chen, Han; Chai, Tengjiao; Ye, Zeyao; Chen, Hanguang; Xu, Qi; Du, Yian; Yu, Pengfei

Efficacy of chemotherapy combined with surgical resection for gastric cancer with synchronous ovarian metastasis: A propensity score matching analysis

化疗联合手术切除治疗伴同步卵巢转移的胃癌的疗效:倾向评分匹配分析

Fang, Jingquan; Huang, Xingmao; Chen, Xiangliu; Xu, Qi; Chai, Tengjiao; Huang, Ling; Chen, Han; Chen, Hang; Ye, Zeyao; Du, Yian; Yu, Pengfei

Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study

局部晚期胃癌D2根治术后,腹腔热灌注化疗(HIPEC)联合全身化疗与单纯全身化疗的疗效比较:一项随机对照研究

Yu, Pengfei; Huang, Xingmao; Huang, Ling; Dai, Gaiguo; Xu, Qi; Fang, Jingquan; Ye, Zeyao; Chai, Tengjiao; Du, Yian